HCL Tech, Cadila Healthcare, Glenmark Pharma in spotlight
Here is the list of top stocks that could be in focus on September 21, Tuesday.
Indian equity benchmarks ended in deep red on Monday, pulled down by the metal stocks. Today, the start is likely to be positive despite weak cues from global markets. Traders will be getting support with a private report stating that Investors have been pouring money into India’s stock market, and it could grow to more than $5 trillion to become the fifth largest in the world within three years. It added Indian start-ups have raised $10 billion through IPOs so far this year. More support can come as India has climbed two spots to 46 in the Global Innovation Index (GII) 2021 prepared by the World Intellectual Property Organization (WIPO). The country’s rank has been consistently rising in the last few years. From 81 in 2015, it has moved to 46 in 2021. Traders may take note of the report that apex exporters’ body Federation of Indian Export Organisations (FIEO) said it will focus on new products and markets for diversification with a view to boost the country’s outbound shipments. Here is the list of top stocks that could be in focus on September 21, Tuesday.
HCL Technologies: The IT major announced a five-year, digital transformation deal with MKS Instruments Inc., a global provider of instruments, systems, subsystems and solutions for advanced manufacturing processes, to improve performance, productivity and speed to market.
SBI Cards: Shares of SBI Cards and Payment Services will be in focus. CA Rover Holdings, an affiliate of Carlyle Asia may reportedly sell 3.2 crore shares in the company through a block trade. Shares are being offered at Rs 1,021 to Rs 1,072.3 each.
Cadila Healthcare: Zydus Healthcare, a wholly owned subsidiary of Cadila Healthcare has entered into an agreement with Integrace Private Limited (‘Purchaser’) to sell two brands viz. Mifegest and Cytolog.
Glenmark Pharmaceuticals: Glenmark Pharmaceuticals (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Clindamycin Phosphate Foam, 1%, the generic version of Evoclin1 Foam, 1%, of Mylan Pharmaceuticals Inc.
Kitex Garments: Kitex Garments has signed the Memorandum of Understanding (MoU) with Telangana State Government for investing Rs. 2,406 crores in the state of Telangana. The investment is planned at Kakatiya Mega Textile Park, Warangal and Industrial Park, Sitarampur, Rangareddy District.
Action Construction Equipment: The company launched its Qualified Institutions Placement on Monday. The floor price has been fixed at Rs 254.55 per share for the offer.
Powered by Capital Market – Live News
Download Money9 App for the latest updates on Personal Finance.
